The focus of the Beinat Lab research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
We are seeking passionate and dedicated lab members to contribute to our dynamic research environment. Our lab focuses on radiopharmaceutical development for molecular imaging and targeted radionuclide therapy of cancer, and we aim to push the boundaries of knowledge while fostering innovation and collaboration.
Qualifications:
We seek postdoctoral fellows with a PhD in chemistry, radiochemistry, molecular imaging, cancer biology, or related field to join our growing team. We encourage individuals with strong problem-solving skills, attention to detail, excellent communication and interpersonal skills to apply.
What We Offer:
A supportive and collaborative research environment.
Opportunities for professional development and mentorship.
Access to advanced resources and technology.
If you’re excited about contributing to our research and working alongside a dedicated team, we want to hear from you! Please submit your CV and a brief cover letter outlining your interests and relevant experience to cbeinat@stanford.edu